Published in Liver Int on February 25, 2011
Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays. Thromb J (2014) 1.05
Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review. World J Gastroenterol (2014) 0.86
Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes? ScientificWorldJournal (2014) 0.77
Dosing and monitoring of low-molecular-weight heparin in cirrhotic patients. Liver Int (2011) 0.77
Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis. PLoS One (2014) 0.75
Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int (2010) 2.96
Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc (2005) 3.28
Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg (2012) 3.28
The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg (2008) 2.45
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl (2005) 2.35
Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl (2008) 2.30
Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation (2012) 2.26
Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology (2010) 2.25
Shared decision making in transplantation: how patients see their role in the decision process of accepting a donor liver. Liver Transpl (2014) 2.01
Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler Thromb Vasc Biol (2007) 1.85
Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol (2011) 1.85
Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization. Ann Surg (2008) 1.79
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75
Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg (2009) 1.70
Long-term results of urgent revascularization for hepatic artery thrombosis after pediatric liver transplantation. Liver Transpl (2010) 1.68
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol (2009) 1.65
The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. Blood (2008) 1.59
Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med (2006) 1.56
Who should get a liver graft? J Hepatol (2009) 1.56
Cell-collagen interactions: the use of peptide Toolkits to investigate collagen-receptor interactions. Biochem Soc Trans (2008) 1.56
Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology (2006) 1.50
Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg (2010) 1.50
Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int (2008) 1.50
Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood (2010) 1.49
Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver Int (2013) 1.47
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression. Transplantation (2008) 1.43
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol (2012) 1.42
The hemostatic status of pediatric recipients of adult liver grafts suggests that plasma levels of hemostatic proteins are not regulated by the liver. Blood (2010) 1.40
Anastomotic biliary strictures after liver transplantation: causes and consequences. Liver Transpl (2006) 1.32
Biliary complications after liver transplantation: a review. Scand J Gastroenterol Suppl (2006) 1.31
Impact of blood loss on outcome after liver resection. Dig Surg (2007) 1.28
Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl (2009) 1.21
Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg (2006) 1.17
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood (2010) 1.16
Matrix metalloproteinase 2 genotype is associated with nonanastomotic biliary strictures after orthotopic liver transplantation. Liver Int (2011) 1.15
Nonanastomotic biliary strictures after liver transplantation, part 2: Management, outcome, and risk factors for disease progression. Liver Transpl (2007) 1.12
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl (2010) 1.09
Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis. Hepatology (2015) 1.08
The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation. Liver Int (2010) 1.08
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion (2006) 1.07
Bleeding in liver surgery: prevention and treatment. Clin Liver Dis (2009) 1.06
Nonanastomotic biliary strictures after liver transplantation, part 1: Radiological features and risk factors for early vs. late presentation. Liver Transpl (2007) 1.03
Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol (2011) 1.02
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int (2011) 1.02
Role of fibrin sealants in liver surgery. Dig Surg (2012) 1.01
Platelets in liver transplantation: friend or foe? Liver Transpl (2008) 0.99
Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl (2012) 0.99
Protection of bile ducts in liver transplantation: looking beyond ischemia. Transplantation (2011) 0.98
Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant (2005) 0.98
Smoking behavior in liver transplant recipients. Liver Transpl (2009) 0.97
Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg (2005) 0.96
Topical haemostatic agents in liver surgery: do we need them? HPB (Oxford) (2009) 0.95
Liver transplantation with preservation of the inferior vena cava. A comparison of conventional and piggyback techniques in adults. Clin Transplant (2004) 0.95
An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology (2013) 0.94
Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men. Blood (2010) 0.93
P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression. Clin Cancer Res (2005) 0.93
A benefit-risk review of systemic haemostatic agents: part 1: in major surgery. Drug Saf (2008) 0.93
Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg (2004) 0.93
Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver. Eur J Pharm Sci (2009) 0.93
Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients. Hepatology (2005) 0.91
Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. J Hepatol (2013) 0.90
Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol (2004) 0.90
Hypofibrinolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis. Thromb Haemost (2005) 0.90
Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol (2008) 0.90
Regeneration of human extrahepatic biliary epithelium: the peribiliary glands as progenitor cell compartment. Liver Int (2011) 0.90
Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford) (2009) 0.90
Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts. J Vasc Surg (2006) 0.89
Surgical injuries of postmortem donor livers: incidence and impact on outcome after adult liver transplantation. Liver Transpl (2006) 0.89
The sequence of revascularization in liver transplantation: it does make a difference. Liver Transpl (2006) 0.89
Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss. Dig Surg (2007) 0.89
Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient. Liver Int (2013) 0.88
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis. PLoS Med (2008) 0.88
Beneficial effects of gaseous hydrogen sulfide in hepatic ischemia/reperfusion injury. Transpl Int (2012) 0.88
Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/- mice. Hepatology (2006) 0.88
Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy. Liver Transpl (2014) 0.87
Expression and regulation of the bile acid transporter, OSTalpha-OSTbeta in rat and human intestine and liver. Biopharm Drug Dispos (2009) 0.87
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience. Transplantation (2013) 0.87
Circulating endothelial cells in cancer patients do not express tissue factor. Cancer Lett (2004) 0.87
Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis. Transpl Int (2010) 0.87
Activation and regulation of hemostasis in acute liver failure and acute pancreatitis. Semin Thromb Hemost (2010) 0.87
The origin of biliary strictures after liver transplantation: is it the amount of epithelial injury or insufficient regeneration that counts? J Hepatol (2013) 0.86
Graft loss after pediatric liver transplantation. Ann Surg (2002) 0.85
The role of bile salt toxicity in the pathogenesis of bile duct injury after non-heart-beating porcine liver transplantation. Transplantation (2008) 0.85
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels. Blood (2006) 0.85
Prevalence of psychological problems and associated transplant-related variables at different time periods after liver transplantation. Liver Transpl (2015) 0.85
Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury. Thromb Haemost (2004) 0.85
The role of platelets in liver inflammation and regeneration. Semin Thromb Hemost (2010) 0.85